Unilever's offer for GSK's consumer health raises doubts, questions over strategy
Skip to main content
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
The Business Standard
SATURDAY, MAY 28, 2022
SATURDAY, MAY 28, 2022
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
Unilever's offer for GSK's consumer health raises doubts, questions over strategy

Global Economy

Reuters
17 January, 2022, 09:40 pm
Last modified: 17 January, 2022, 09:45 pm

Related News

  • Unilever's strategies for success in a competitive market
  • Horlicks mini pack fuels Unilever Consumer Care profit
  • Horlicks bounces back in 2021, Unilever Consumer’s profit flat
  • Healthcare companies Sanofi and GSK to seek Covid-19 vaccine regulatory approval
  • Unilever says it wants to buy GSK's consumer goods arm

Unilever's offer for GSK's consumer health raises doubts, questions over strategy

The bid for GSK's assets, including Sensodyne toothpaste and Advil painkillers, comes as Unilever is dealing with steep inflation and sluggish growth in emerging markets, where it derives 60% of its revenues

Reuters
17 January, 2022, 09:40 pm
Last modified: 17 January, 2022, 09:45 pm
Unilever's offer for GSK's consumer health raises doubts, questions over strategy

Unilever faces a dilemma after its 50 billion pound ($68 billion) offer for GlaxoSmithKline's consumer healthcare assets was rejected -- should it raise the bid and risk overpaying or seek another route to expand in healthcare?

The bid for GSK's assets, including Sensodyne toothpaste and Advil painkillers, comes as Unilever is dealing with steep inflation and sluggish growth in emerging markets, where it derives 60% of its revenues.

Chief Executive Alan Jope, in the role since 2019, is also facing shareholder pressure over a languishing stock price, which fell as much as 8% on Monday after its bid became public.

Analysts said digesting GSK's consumer health assets at a price of over 50 billion pounds in cash and stock, would nearly triple Unilever's leverage towards 5.6 times in the first year from 2 times net debt to EBITDA currently.

"The leverage implied by such a deal would make it less likely they turn around their core business," Bernstein analyst Bruno Monteyne said, pointing to Unilever's added balance sheet pressure and limited ability to invest behind brands.

Food to go?

Unilever on Monday also announced plans to focus more on health, beauty and hygiene products, after an extensive review of its businesses.

This points to a potential spin off or disposal of its Foods business, at least three brokerages said. However, letting go of a cash-generative business could be detrimental at this time, they said, and it would be difficult for Unilever to sell the entire business to a single buyer.

HSBC analysts said the GSK move added to uncertainty over where Unilever was heading.

"Unilever's approach is likely to raise a number of questions over what it might do next from both an M&A standpoint and in terms of the structure of its own business," HSBC analyst Jeremy Fialko said in a note.

Previous exprience 

Analysts expressed concerns about Unilever's track record with acquisitions, highlighting its purchase Dollar Shave Club for 1 billion in 2016 which they said had failed to make a major mark on its fortunes.

HSBC pointed to the company's last big acquisition - Bestfoods for $25 billion in 2000 - which saddled it with slow growth, middle of the aisle food brands, which Unilever has trimmed via the sale of tea and spreads businesses.

"The patchy historical track record of large transactions in the sector - and indeed Unilever's last really big acquisition, Bestfoods - is also likely to be at the forefront of investors' minds," HSBC said.

Bernstein's Monteyne said big consumer goods deals do not pay out as it is "impossible" to eke out very high growth rates on such large businesses, pointing to Reckitt Beckiser's Mead Johnson deal and Danone's (DANO.PA) Whitewave foods acquisition.

Margin impact 

Analysts also said a GSK deal could significantly erode Unilever's stable operating margins of 18-19%, a big draw for long term investors, saying it offers only a mid-single digit return on investment, when accounting for cost savings and revenue synergies.

Berenberg analyst James Targett said he doubted the deal would provide Unilever the organic growth lift it is seeking, pointing to GSK's Consumer Health business's 1% average growth over the past 20 quarters, compared with 3% for Unilever.

Uncharted waters 

While GSK's consumer assets would bolster Unilever's presence in the oral care and vitamins and supplements category, it would also bring over-the-counter drugs, such as Panadol and Advil, to its roster.

RBC Capital Markets said GSK's large portfolio of products with clinical/medical characteristics and consequently regulatory obstacles could restrict Unilever's ability to roll the acquired brands into new markets as it does with consumer brands.

"We can't imagine many things that would unnerve us more

about Unilever than acquiring GSK consumer health," RBC's James Targett wrote.

"We see little justification for such a deal strategically, operationally or financially."

($1 = 0.7331 pounds)

Top News / World+Biz

GSK / Uniliver / Uniliver Consumer Care / GSK's consumer goods

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Plucking the poultry: New tax regime for the sector on cards
    Plucking the poultry: New tax regime for the sector on cards
  • Dr Zahid Hussain. Illustration: TBS
    The economics of remittance subsidy
  • The government needs to continue subsidising both agriculture and non-agriculture sectors to keep inflation under control Photo: Mumit M/TBS
    Commodity rally continues

MOST VIEWED

  • U.S. one dollar banknotes are seen in this illustration taken February 8, 2021. REUTERS/Dado Ruvic/Illustration/File Photo/File Photo
    US Treasury pushes Russia towards default: What next?
  • The OPEC logo pictured ahead of an informal meeting between members of the Organization of the Petroleum Exporting Countries (OPEC) in Algiers, Algeria, September 28, 2016. REUTERS/Ramzi Boudina
    G7 calls on OPEC to play key role to ease global energy supplies
  • A maze of crude oil pipes and valves is pictured during a tour by the Department of Energy at the Strategic Petroleum Reserve in Freeport, Texas, U.S. June 9, 2016. REUTERS/Richard Carson
    Oil on track for weekly rise on global supply concerns
  • A participant stands near a logo of World Bank at the International Monetary Fund - World Bank Annual Meeting 2018 in Nusa Dua, Bali, Indonesia, October 12, 2018. Photo :Reuters
    G20 pandemic fund ploughs ahead amid fears world not ready for future threats
  • A Russian rouble banknote is placed on euro banknotes in this illustration taken March 1, 2022. REUTERS/Dado Ruvic/Illustration/File Photo
    Russian central bank allows share purchases in companies from 'friendly' countries
  • Shoppers browse in a supermarket while wearing masks to help slow the spread of coronavirus disease (Covid-19) in north St. Louis, Missouri, US April 4, 2020. REUTERS/Lawrence Bryant/File Photo
    US consumer spending beats expectations in April; inflation likely peaked

Related News

  • Unilever's strategies for success in a competitive market
  • Horlicks mini pack fuels Unilever Consumer Care profit
  • Horlicks bounces back in 2021, Unilever Consumer’s profit flat
  • Healthcare companies Sanofi and GSK to seek Covid-19 vaccine regulatory approval
  • Unilever says it wants to buy GSK's consumer goods arm

Features

The taboo of dining out alone

The taboo of dining out alone

17h | Food
The perfect time for newborn photography is between the first five and 14 days when a baby’s bones are the most malleable for posing. Photo: Courtesy

Is there a market for newborn photography in the country? Studio Picturerific says yes

17h | Panorama
Pakistan finds itself in political turmoil again as Imran Khan pushes for immediate general elections. Photo: Reuters

Supreme Court of Pakistan: Now a candle in the dark

18h | Analysis
Indulge in Momium’s guilt-free dips and spreads

Indulge in Momium’s guilt-free dips and spreads

19h | Food

More Videos from TBS

Fear of food crisis sets across the globe

Fear of food crisis sets across the globe

13h | Videos
Is Mushfiq refraining from self-destructive shots?

Is Mushfiq refraining from self-destructive shots?

13h | Videos
Kanak is ahead of everyone in Guinness Book

Kanak is ahead of everyone in Guinness Book

18h | Videos
What should your CV cover letter look like?

What should your CV cover letter look like?

20h | Videos

Most Read

1
Bangladesh at risk of losing ownership of Banglar Samriddhi
Bangladesh

Bangladesh at risk of losing ownership of Banglar Samriddhi

2
Corporates go cashless…tax cut on cards
NBR

Corporates go cashless…tax cut on cards

3
Photo: Courtesy
Panorama

Misfit Technologies: A Singaporean startup rooted firmly in Bangladesh

4
Tk100 for bike, Tk2,400 for bus to cross Padma Bridge
Bangladesh

Tk100 for bike, Tk2,400 for bus to cross Padma Bridge

5
British International Investment (BII) CEO Nick O’Donohoe. Illustration: TBS
Economy

BII to invest $450m in Bangladesh in 5 years

6
Representational image. Picture: Pixabay
Economy

Govt raises regulatory duty to discourage imports of 130 products

The Business Standard
Top
  • Home
  • Entertainment
  • Sports
  • About Us
  • Bangladesh
  • International
  • Privacy Policy
  • Comment Policy
  • Contact Us
  • Economy
  • Sitemap
  • RSS

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net

Copyright © 2022 THE BUSINESS STANDARD All rights reserved. Technical Partner: RSI Lab